Steven Petrou
Fondatore presso PRAXIS PRECISION MEDICINES, INC.
Posizioni attive di Steven Petrou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 | - |
| Fondatore | 22/09/2015 | - | |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Direttore Tecnico/Scientifico/R&S | - | - |
| Fondatore | - | - |
Storia della carriera di Steven Petrou
Precedenti posizioni note di Steven Petrou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
The Florey Institute of Neuroscience & Mental Health
 The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Direttore/Membro del Consiglio | 01/07/2018 | 01/11/2022 |
| Corporate Officer/Principal | 01/07/2018 | 01/11/2022 |
Formazione di Steven Petrou
| University of Melbourne | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Australia | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
The Florey Institute of Neuroscience & Mental Health
The Florey Institute of Neuroscience & Mental Health Miscellaneous Commercial ServicesCommercial Services The Florey Institute of Neuroscience & Mental Health operates as brain research center. Its teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neuron disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. The company was founded in July 2007 and is headquartered in Parkville, Australia. | Commercial Services |
- Borsa valori
- Insiders
- Steven Petrou
- Esperienza
